Biological membranes of many tissues and organs contain large-pore channels designed to permeate a wide variety of ions and metabolites. Examples include connexin, innexin, and pannexin, which form gap junctions and/or bona fide cell surface channels. The most recently identified large-pore channels are the calcium homeostasis modulators (CALHMs), which permeate ions and ATP in a voltage-dependent manner to control neuronal excitability, taste signaling, and pathologies of depression and Alzheimer's disease. Despite such critical biological roles, the structures and patterns of oligomeric assembly remain unclear. Here, we reveal the first structures of two CALHMs, CALHM1 and CALHM2, by single particle cryo-electron microscopy, which show novel assembly of the four transmembrane helices into channels of 8mers and 11-mers, respectively. Furthermore, molecular dynamics simulations suggest that lipids can favorably assemble into a bilayer within the larger CALHM2 pore, but not within CALHM1, demonstrating the potential correlation between pore-size, lipid accommodation, and channel activity.
with the respective recombinant baculoviruses (12) , purified, and reconstituted into lipid nanodiscs prior to vitrification for the cryo-EM study ( fig. S2 ; also see Supplementary Methods).
We solved the structure of chCALHM1 using single particle cryo-EM analysis at an overall resolution of 3.63 Å (Fig. 1C-E, fig. S3-4 , table S1) as assessed by Fourier Shell Correlation (FSC) (13, 14) . The cryo-EM structure was solved in the absence of calcium, and therefore likely represents the active state. The cryo-EM density of the extracellular domain, the four TMD helices, and the cytoplasmic helices (CTHs) were of sufficient quality to conduct de novo modeling between residue numbers 26-79, 91-137 and 151-247, altogether spanning 198 out of 342 amino acids. Most of the missing density is in the carboxyl terminal region after the CTH where 72 out of 94 residues are predicted to be unstructured by a secondary structure analysis (15) . Nevertheless, the structure confirms the previous prediction that CALHM1 harbors four transmembrane domains with the amino and carboxyl termini facing the cytoplasm (16) . The cryo-EM density for TMD1 facing the pore is weaker compared to the other three TMDs, indicating the presence of conformational flexibility. Some unresolved density extends from TMD1 towards the middle of the channel at the cytoplasmic side, likely representing the amino terminal residues in multiple conformations ( fig. S5) . In CALHM1s from human and Caenorhabditis elegans, the first nine residues have been shown to alter voltage-sensitivity (17) , thus, we suggest that these voltagesensing residues are located in the inner-pore within the membrane spanning region ( fig. S5) . Our current structure clearly showed octameric assembly with the pore-like structure in the middle of the oligomer (Fig. 1C-D) . The assembly is mediated mainly by interactions between TMD2 and TMD4, between TMD1 and TMD3, and between the forty-residue long CTHs of neighboring subunits ( fig. S6) . The octameric assembly shown in our high resolution cryo-EM structure differs from a previous study suggesting hexameric assembly of CALHM1 based on Blue Native-PAGE and photobleaching of the hCALHM1-EGFP constructs (16) . Nevertheless, the subunit-interface residues are highly conserved between chCALHM1 and hCALHM1 strongly implying preservation of oligomeric mechanisms ( fig. S1 and S6 , 88.5%/100% identity/similarity over 35 residues in TMDs and CTH). The only other octameric channel reported to date is innexin (18) , however, it does not share similar features in the pattern of oligomeric assembly with chCALHM1.
Furthermore, contrary to a previous suggestion, there is no similarity in the membrane topology, structure, and oligomeric assembly pattern of chCALHM1 to N-methyl-D-aspartate (NMDA) receptors(1) which contain three TMDs and a re-entrant loop and form hetero-tetramers (19, 20) .
Importantly, the structural comparison of monomers demonstrated that chCALHM1 does not resemble other four transmembrane channel proteins including connexin (CX26) (21) , innexin (INX6) (18) , or the volume-regulated anion channel (VRAC; LRRC8)(22, 23) ( Fig. 1F) .
A key residue known to modulate CALHM1 ion permeability and calcium sensitivity, Asp120 (Asp121 in hCALHM1) (11) , is located in TMD3 at the interface with the neighboring subunit ( fig. S6A-C) . Although in chCALHM1, each of the Asp120 residues face the inner pore, they do not appear to participate in pore formation directly as they are distant from each other (~20 Å apart between the Cαs of the neighboring Asp120 residues). Instead, Asp120 may facilitate inter-subunit interactions which stabilize channel assembly ( fig. S6C ). Mutation of another key residue in hCALHM1 (Pro86Leu) has also previously been shown to be a risk factor for the age of onset of Alzheimer's disease in selected populations(1), and although the equivalent residue in chCALHM1 is Gln85, it is clear that this residue is located in the disordered loop between TMD2 and TMD3. Consistent with this location, which faces the cytoplasm and is not part of the channelpore ( fig. S6A-B ; asterisks), the Pro86Leu mutation in hCALHM1 has previously been shown not to alter channel activity(1). Instead, the mechanisms underlying the association of this mutations with Alzheimer's disease pathology may involve other factors, such as protein-protein interactions involving this loop and subsequent cell signaling events that regulate the level of amyloid beta (24) .
CALHM2 has a moderately high sequence similarity to CALHM1 within the predicted TMD domains (35%/56% and 37%/55% between hCALHM1 and hCALHM2 and between chCALHM1 and hCALHM2, respectively (identity%/similarity%); fig. S7 ), yet, unlike CALHM1, does not show voltage-dependent ion channel activities (8) . Thus, we wondered what structural features of CALHM1 and CALHM2 may be responsible for this functional difference. To permit an extensive comparison, we conducted a structural analysis of the human CALHM2 (hCALHM2) protein by implementing a similar protocol to that used above for chCALHM1 ( fig. S8 , also see Supplementary Methods). Single particle cryo-EM analysis of the hCALHM2 sample in the absence of calcium resulted in one major 3D class at 3.48 Å resolution as assessed by FSC ( fig. S9-10, table S1). As in the case of chCALHM1, the hCALHM2 protomer contains four TMDs and the long CTH that is the signature of the CALHM family ( Fig. 2A-B, D) . The orientations of the four TMD helices in hCALHM2 are also similar to that of chCALHM1 and unrelated to connexin (CX26), innexin, or VRAC ( Fig. 2E) . However, the profound structural difference between chCALHM1 and hCALHM2 is that the oligomeric state of hCALHM2 is 11-mer. As in chCALHM1, the oligomeric assembly of hCALHM2 is mediated by interactions between TMD2 and TMD4, between TMD1 and TMD3, and between the CTHs of the neighboring subunits ( fig.   S11 ). However, the fundamental difference is in the angle between TMD4 and the CTH, which is controlled by the linker sequence that tethers these two helices together (TMD-CTH linker; Fig.   2E ). Consequently, the sites of inter-CTH interactions are different between chCALHM1 and hCALHM2. This linker sequence differs between CALHM family members, suggesting that CALHM4-6 may also have distinct oligomeric states ( fig. S6 ). It is interesting to note that CALHM1 and CALHM3 have similar linker sequences and are known to form heteromers (8) .
Nevertheless, the 11-mer channel assembly observed in hCALHM2 is unprecedented. Therefore, to validate the physiological relevance of this 11-mer assembly in the membrane environment, we conducted a series of disulfide-based inter-subunit crosslinking experiments (Fig. 2C) . Based on the structure, we substituted residues in the inter-subunit interface at the extracellular side of TMD2 and TMD4 (Arg52/Tyr182) and at the CTHs (Asn226/Arg240) with cysteines ( Fig. 2C) , subjected the mutants to SDS-PAGE, and detected bands by Western blot in the presence and absence of a reducing agent. In the case of CTH mutants located in the cytoplasm, we facilitated disulfide bond formation by addition of copper phenanthroline to the membrane fraction. In the non-reducing condition, we observed a high molecular weight band around 460 kDa. Monomer bands were exclusively observed in the reducing condition, indicating that the band shift in the non-reducing condition is mediated by disulfide bonding between the engineered cysteines ( Fig.   2C ). The resolution of the Western blot experiment is not sufficiently high to unambiguously assign 11-mer assembly, however, the result shows that the oligomeric assembly observed in the cryo-EM structure is consistent with its physiological state in the membrane.
One noteworthy observation is that the hCALMH2 11-mer dimerizes to form a 22-mer reminiscent of a gap junction in the presence of 1 mM CaCl2 under cryo-EM conditions ( fig. S12-13 ). Our 22-mer structure solved at 3.68 Å showed a high structural similarity to the 11-mer structure (RMSD = 0.853 Å over 265 residues), indicating that the calcium did not alter the protein architecture. Inclusion of 1 mM CaCl2 does not oligomerize hCALHM2 to a 22-mer assembly in solution as observed in the identical peak retention time in size-exclusion chromatography, thus, whether this gap junction structure observed under the cryo-EM condition is physiological or not remains unresolved at this point. However, similar gap junction formation was also observed in cryo-EM images of chCALHM1 under similar conditions (data not shown), indicating the propensity of the CALHM channels to form dimers in the presence of calcium under cryo-EM conditions.
Further structural inspection revealed that the majority of the channel-lining residues (TMD1 and 3) in chCALHM1 are hydrophilic ( Fig. 3A-B) whereas those in similar positions in hCALHM2 are hydrophobic ( Fig. 3C-E) . Thus, we speculated that hydrophobic molecules, for example lipids, may be favorably placed in this hydrophobic channel-like structure of hCALHM2.
This speculation was partially supported by our observation of amorphous density in the middle of the 11-mer assembly in hCALHM2 ( Fig. 3F) , which is not present in the octameric chCALHM1. To assess if the 11-mer channel-like structure in hCALHM2 can accommodate lipids in the middle, we conducted molecular dynamics simulations of chCALHM1 and hCALHM2 in the presence of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) ( Fig. 3G-H) . Coarsegrained structural models(25) of chCALHM1 and hCALHM2 were mixed with POPC lipids and allowed to self-assemble into bilayers (26) . During replicates of 500 ns simulations, a membrane bilayer formed around both proteins within the first 100 ns, with a number of lipids inside the channel pore. In hCALHM2, the central pore lipids were oriented with a bilayer-like configuration that remained stable, both in simulations of the protein-membrane systems upon conversion into their corresponding atomistic representation as well as in further, extended coarse-grained simulations (up to 5 µs per replicate) ( Fig. 3H) . By marked contrast, however, although phospholipids could also be accommodated within the smaller chCALHM1 pore, they did not assemble into clearly defined or stable inner and upper leaflets (Fig. 3H) . These simulations imply that the hydrophobicity and larger 11-mer assembly of hCALHM2 may favor the accommodation of lipid molecules, which prevent ion permeation.
In conclusion, our study demonstrates that CAHLM1 and CALHM2 assemble as 8-mer and 11-mer, respectively, and that these different oligomeric states of CALHMs correlate with channel functions, with only the smaller 8-mer assembly displaying ion channel activity. The structural information presented here will serve as the foundation to study mechanistic questions and reagents development for CALHMs. 
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Materials and Methods Expression, purification, and nanodisc reconstitution of CALHM1 and CALHM2
The chCALHM1 construct with N-terminally fused Strep-II, 8xHis, and EGFP tags (StrepII2-His8-GFP) and the hCALHM2 construct with a C-terminally fused Strep-II tag were expressed in the baculovirus (BV)/Sf9 system under the Drosophila Hsp70 promoter as previously described (12) . In brief, Sf9 cells were cultured in CCM3 (Invitrogen) supplemented with 1% non- Bio-Beads (BioRad) overnight (~12 hours). The beads were removed and the solution was further purified by size exclusion chromatography using a Superose 6 10/300 column (GE Healthcare) in 20 mM Tris-HCl pH 8.0, 200 mM NaCl, 1 mM EDTA. Peak fractions were pooled and concentrated to ~2.5 mg/ml (hCALHM2) or ~0.6 mg/ml (chCALHM1) for cryo-EM grid preparation. MSP2N2 protein was expressed and purified as previously described (29) .
Cryo-EM sample preparation, image collection and single particle analysis
3-4 µl of the CALHM-nanodisc complex was applied to glow-discharged 1.2/1.3 400 mesh C-flat carbon coated copper grids (Protochips). The grids were blotted for 4 s with blot force 7 at 85% humidity and 15°C prior to plunge freezing into liquid ethane using a Vitrobot Mark IV (Thermo Fisher). Datasets were collected using a Titan Krios operated at an acceleration voltage of 300 keV and the GATAN K2 Summit direct electron detector coupled with the GIF quantum energy filter (Gatan Inc.) controlled by SerialEM software (30) . Movies were recorded with a pixel size of 1.06 Å, an exposure time of 10 s over 50 frames, and a dose rate of 1.4 e/Å 2 /frame. The program Warp was used to align movies, estimate the CTF and pick particles (31) . 2D classification, ab-initio 3D map generation, 3D refinement, 3D classification, per particle CTF refinement and B-factor sharpening were performed using the program cisTEM (32) . The highest resolution of 3D refinement used was 6 Å for all of the models in this study. The workflows of single particle analyses for chCALHM1 and hCALHM2 are outlined in fig. S3 and S9. De novo modeling was done manually using the program Coot (33) . The final models were refined against the cryo-EM maps using PHENIX real space refinement(34) with secondary structure and Ramachandran restraints. The FSCs were calculated by phenix.mtriage. Data collection and refinement statistics are summarized in table S1.
Cysteine crosslinking and Western blot analysis
The cysteine substituted Asn226Cys/Arg240Cys hCALHM2 and Arg52Cys/Tyr182Cys hCALHM2, as well as wild-type hCALHM2, were all C-terminally 1D4 tagged and expressed in the BV/Sf9 expression system under the CMV promoter. The membrane fraction were isolated and solubilized as above. The solubilized fraction was subjected to affinity purification by 1D4 antibody conjugated to CNBr-activated agarose (GE Healthcare). The resin was extensively washed and the protein eluted with wash buffer supplemented with 0.2 mg/ml 1D4 peptide.
Samples were then either reduced with β-mercaptoethanol, left untreated, or treated with the oxidizing agent (1,10-phenanthroline) copper(II). After 30 min incubation on ice, 1 mM final concentration iodoacetamide was added to samples treated with (1,10-phenanthroline) copper(II).
Samples were subjected to Western blot using anti-1D4 monoclonal antibodies (University of British Columbia) and anti-mouse Horseradish peroxidase-conjugated antibodies (GE Healthcare).
Protein bands were detected by enhanced chemiluminescence on X-ray film (ECL kit; GE Healthcare). To verify that the in-membrane hCALHM2 assembly corresponded in size to detergent extracted hCALHM2, the membrane fractions containing Asn226Cys/Arg240Cys hCALHM2-1D4 were also oxidized with (1,10-phenanthroline) copper(II) prior to detergent solubilization.
Molecular dynamics
Molecular structures of chCALHM1 and hCALHM2 were separately embedded within POPC bilayer membranes that were solvated on either side at 0. Each protein-membrane system was assembled and equilibrated via a previously established protocol (26) . Simulations were performed with GROMACS 5.1 (35) . The MARTINI 2.2 force field(25) was used for coarse-grained simulations, with a time-step of 20 fs and an elastic network used to harmonically restrain Cα particles and stabilize the protein structure. Atomistic simulations were run using the OPLS all-atom protein force field with united-atom lipids (36) and the TIP4P/2005 water model (37) . The integration time-step was 2 fs. Temperature and pressure were maintained at 37°C and 1 bar during simulations, using the velocity-rescaling thermostat (38) in combination with a semi-isotropic Parrinello and Rahman barostat (39) , with coupling constants of τT = 0.1 ps and τP = 1 ps, respectively. Bonds were constrained through the LINCS algorithm (40) .
A Verlet cut-off scheme was applied, and long-range electrostatic interactions were calculated using the Particle Mesh Ewald method (41) . 1550B digitizer (Axon Instruments) using a sampling frequency of 10 kHz. Recordings were analyzed using the Clampex 11.0 software (Axon Instruments). Patches were held at -60 mV and stepped between -100 mV and +100 mV in 20 mV increments for 1 s.
Electrophysiology

Fig. S1. Sequence alignment of CALHM1 orthologues A multiple sequence alignment of CALHM1 orthologues (Gallus gallus, Homo sapiens, Caenorhabditis elegans and Danio rerio).
Red boxes indicate identical residues and red characters indicate similar residues. The positions of the TMD1-4 (red bars above the alignment), the CTH (the grey bar above the alignment), and the 'linker' are based on the chCALHM1 structure from the current study. An asterisk and an arrow annotate Asp120 and the position of Pro86 in Homo sapiens CALHM1 (Glu85 in chCALHM1), respectively. The multiple sequence alignment was generated using Clustal Omega (42) and graphically presented using ESPript 3.0(43). The positions of the TMD1-4 (red bars above the alignment), the CTH (the grey bar above the alignment), and the 'linker' are based on the hCALHM2 structure from the current study. The multiple sequence alignment was generated as in fig. S1 . Polar and van der Waals interactions mediated by hydrophobic residues (ovals) are shown as dashed and solid lines, respectively. The lines in magenta are the conserved interactions between chCALHM1 and hCALHM2. The residues in italic are the equivalent ones in hCALHM1 in a sequence alignment. 
